Pacira Pharmaceuticals (PCRX): Total Asset Value of Company

Graphic logo of Pacira (PCRX)

The chart-confirmed market price of Pacira BioSciences (PCRX) total assets is 1394.29. The current trend is clouded by the threat of expansion from Exparel generics, which could crash future revenues. The business relies on strict adherence to temperature controls during the delivery of analgesics to clinics. Meanwhile, management is effectively defending intellectual property and expanding its share in the non-narcotic drug segment.

Pacira BioSciences (PCRX) Company Total Assets: for the period 07/04/2022 - 10/28/2026

Comprehensive metric breakdowns and analytics for Pacira (PCRX)

- price and consensus price forecast:
Share Price pacira.com|PCRX - Price Target Chart
- market capitalization data:
Market Valuation Pacira Corp|PCRX - Enterprise Value
- book capitalization data:
Accounting Value of a Share Pacira BioSciences|PCRX - Book Capitalization|Market Capitalization to Book Value Ratio pacira.com|PCRX - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Pacira BioSciences|PCRX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Pacira Corp|PCRX - Company Aggregate Debts|Debts to Book Capitalization Pacira Corp|PCRX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Pacira BioSciences
Fundamental valuation:PCRX, pacira.com
Finished products of Pacira BioSciences

This indicator measures the aggregate value of Pacira BioSciences (PCRX) resources, calculated inversely via ROA to isolate random market fluctuations from systemic balance sheet transformations. An analysis of balance sheet assets allows for an assessment of how the financial base of Pacira BioSciences aligns with the scale of Exparel's integration into surgical protocols, confirming the fundamental stability of the painless recovery ecosystem.

Competitors of Pacira BioSciences (PCRX)

HLN (haleon.com) - Total Business Assets|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|ARS Pharmaceuticals, Inc. (SPRY) - Cumulative Company Assets|Aggregate Asset Value TBPH (Theravance Biopharma Inc)|AQST: Aggregate Company Assets|SCPH - Company Assets|Cumulative Company Assets Tectonic TECX|TNXP - Aggregate Business Assets|Company Total Assets sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Aggregate Asset Value|Company Total Assets BHST (BioHarvest)|Company Assets EXOZ|Oramed Pharmaceuticals (ORMP) - Aggregate Company Assets|Aggregate Asset Value ENTX (enterabio.com)|MindWalk Holdings Inc. (HYFT) - Aggregate Company Assets|Total Asset Value of Company ABVC BioPharma Inc. ABVC|Cumberland Pharma - Company Total Assets|QNTM - Company Total Assets|FGEN (FibroGen, Inc.) - Company Total Assets|telomirpharma.com (TELO) - Cumulative Company Assets|RANI: Company Total Assets|Company Total Asset Base SNYR|Rallybio Corporation (RLYB) - Aggregate Company Assets|Aggregate Asset Value lexariabioscience.com (LEXX)|Company Total Assets PULM (Pulmatrix, Inc.)|PTHL - Company Total Assets|Cumulative Company Assets Aptorum (APM)|LYRA - Aggregate Asset Value|Impact BioMedical (IBO) - Company Total Assets|TNF Pharmaceuticals, Inc. (TNFA) - Aggregate Company Assets|YCBD: Company Total Assets|Company Total Asset Base PRFX|Altamira Therapeutics - Aggregate Company Assets|Company Assets LIPO (Lipella Pharmaceuticals Inc)|Aggregate Company Assets OPTN|Company Total Asset Base Pieris Pharma PIRS|PROC: Company Total Assets|PTPI - Cumulative Company Assets|Qilian International Holding - Company Total Assets|Acelyrin Inc. (SLRN) - Company Total Asset Base|Company Total Assets TFFP (TFF Pharma)